List view / Grid view
While constraints such as inflation and drug pricing pressures will…
While constraints such as inflation and drug pricing pressures will impact pharma’s growth in 2024, patent expiration of biologics is expected to support the industry over the next few years, research suggests.
The new acquisition grants AstraZeneca rights to a new CAR-T…
The new acquisition grants AstraZeneca rights to a new CAR-T cell therapy with a differentiated manufacturing process that could provide a potential best-in-class blood cancer treatment.
A GlobalData report has revealed the extent to which companies…
A GlobalData report has revealed the extent to which companies will be using AI and big data in drug discovery and development processes.
A report has found that the biggest hurdle for digital…
A report has found that the biggest hurdle for digital transformation in pharma is a lack of specific skills and talents, followed by organisational silos.
The survey indicates that almost all respondents were concerned about…
The survey indicates that almost all respondents were concerned about the COVID-19 pandemic’s effects on company performance, including supply and demand failures.
A new report has predicted that, even though the healthcare…
A new report has predicted that, even though the healthcare sector has been slow on the uptake, blockchain will play a pivotal role, creating new ways for pharmaceutical stakeholders to exchange information.
A survey has shown that the pharmaceutical industry believes R&D…
A survey has shown that the pharmaceutical industry believes R&D will see a lot of benefit from digital transformation and that AI will be at the forefront of this.
Researchers have discovered that pharma companies see the most need…
Researchers have discovered that pharma companies see the most need to invest in data protection and cybersecurity over other technologies.
